Cerulean Pharma Inc. To Present At JMP Securities Healthcare Conference

Published: Jun 17, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass., June 17, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced that Christopher D. T. Guiffre, J.D., Senior Vice President and Chief Business Officer, will present at the JMP Securities Healthcare Conference in New York City on Tuesday, June 24, 2014, at 3:30 p.m. ET.

Help employers find you! Check out all the jobs and post your resume.

Back to news